MDRX

• 2026-05-26 share offering or dilution eventrecentOpen filing ↗
  “…relating to the shares of Common Stock issuable upon conversion of the 0.875% Convertible Senior Notes due 2027 (the “Convertible…”
  +1 more passage from the same document

  • “…Convertible Senior Notes due 2027 (the “Convertible Notes”), between the Company and the Trustee (as may be further amended,…”
• 2026-05-26 capital return (buybacks/dividends)recentOpen filing ↗
  “…period 328,898 shares of treasury stock were reissued upon the exercise of outstanding warrants. Treasury shares were 174.1 million…”
  +1 more passage from the same document

  • “…are held as treasury shares for future use, including employee stock plans or reissuance. No repurchases occurred in 2023 or 2024.…”
• 2026-05-26 regulatory investigationrecentOpen filing ↗
  “…becomes available. The Company generally does not accrue for anticipated legal costs and costs but expenses them as incurred.…”
• 2026-05-26 Department of Justice inquiryrecentOpen filing ↗
  “…which could materially and adversely impact our business, financial condition and operating results. 20 We are facing…”
  +1 more passage from the same document

  • “…of this CID. In May 2022, the Company completed the sale of substantially all of the assets of its HLPP business to Altera.…”
• 2026-05-26 merger or acquisition eventrecentOpen filing ↗
  “…$ 6,050 As of December 31, 2024, the allocation of the purchase price was complete. Koha contributed revenues of $ 8.3 million and…”
  +1 more passage from the same document

  • “…March 2, 2022, by and among Allscripts Healthcare Solutions, Inc., Allscripts Healthcare, LLC, PF2 EIS LLC, Allscripts IHC, LLC,…”

Recorded SEC filings in plain language — not advice or a prediction.